Ivan Cruz-Chamorro, Ph.D., is a Professor at the University of Castilla-La Mancha, Spain, specializing in biochemistry and molecular biology. He began his research career in 2009 and completed his graduate studies at the Department of Biomolecular Sciences, University of Urbino, Italy. Since 2012, he has been a member of the Molecular Neuroimmunoendocrinology Laboratory at the Institute of Biomedicine of Seville. He received his Ph.D. from the University of Seville in 2018, obtaining the highest grade for his dissertation on the health effects of plant bioactive peptides. His research focuses on the immunomodulatory, antioxidant, and metabolic properties of natural-derived bioactive peptides and their potential applications in human health. He has authored numerous articles in international scientific journals and currently collaborates with research groups worldwide, investigating the effects of natural compounds and matrices in metabolic-associated fatty liver disease, multiple sclerosis, and cancer models. He also serves as an invited editor for Special Issues on natural compounds and human health, supervises doctoral research, and participates in several funded research projects.
Ivan Cruz-Chamorro, Ph.D., is a Professor at the University of Castilla-La Mancha, Spain, specializing in biochemistry and molecular biology. He began his research career in 2009 and completed his graduate studies at the Department of Biomolecular Sciences, University of Urbino, Italy. Since 2012, he has been a member of the Molecular Neuroimmunoendocrinology Laboratory at the Institute of Biomedicine of Seville. He received his Ph.D. from the University of Seville in 2018, obtaining the highest grade for his dissertation on the health effects of plant bioactive peptides. His research focuses on the immunomodulatory, antioxidant, and metabolic properties of natural-derived bioactive peptides and their potential applications in human health. He has authored numerous articles in international scientific journals and currently collaborates with research groups worldwide, investigating the effects of natural compounds and matrices in metabolic-associated fatty liver disease, multiple sclerosis, and cancer models. He also serves as an invited editor for Special Issues on natural compounds and human health, supervises doctoral research, and participates in several funded research projects.